Introduction Hexavalent chromium Cr (VI) is a strong oxidizing toxic agent. It penetrates cell membrane and quickly reduced with production of reactive intermediates and reactive oxygen species that react with the DNA causing anomalies in the cell structure. Vitamin E (vit. E) is a lipid soluble antioxidant preventing damage to membranes also selenium (Se) is an essential micronutrient with an antioxidant activity. Aim of the present study was to evaluate the hepatotoxicity, nephrotoxicity, and genotoxicity induced by acute Cr (VI) toxicity. Also, to evaluate and compare the possible protective role of vit. E and Se against that toxicity. Methodology: This study was carried out on 60 adult male albino rats divided into 10 rats of six groups, negative control group, selenium control group (0.5 mg/kg IP for 5 consecutive days), vitamin E control group (125 mg/kg orally for 14 days), Cr (VI) group (10 mg/kg single dose IP), Cr (VI) + Selenium group and hexavalent chromium + Vitamin E group. Liver and kidney function tests, total protein, oxidative stress, antioxidant markers and genotoxic analysis were done to all groups. Result: Acute Cr(VI) toxicity resulted in increased levels of the studied liver, kidney , oxidative stress markers, all forms of chromosomal aberrations and elevation of DNA damage. It decreased levels of total protein and antioxidant markers. Treatment with Se or vit. E resulted in improvement in all these effects. Conclusion& recommendation: Cr (VI) is a hepatotoxic, nephrotoxic, and genotoxic. Se or vit. E has the ability for reduction of these deleterious effects. So it is recommended to do regular medical examination of workers exposed to hexavalent chromium for early detection of any health problem and afford dietary supplementation with vitamin E and selenium.
Introduction
etals are major environmental pollutants (Holland and Avery, 2009) . Human exposure to these heavy metals has risen dramatically due to their extensive use even in domestic applications. (Tchounwou et al., 2012) . Chromium (Cr) is one of the eight metals in top of priority list of the toxic substances (ATSDR , 2011) .
Chromium has two valence states: trivalent chromium Cr(III) and hexavalent chromium [Cr(VI)] (Stout et al., 2009) . Chromium (III) compounds are found in foodstuffs and are essential micronutrients (He et al., 2007) , do physiological functions as lipid, protein, and glucose metabolism (IPCS, 2006) , it is safe and has no toxic effects due to its poor ability to enter cells (Zhitkovich, 2011) . Chromium (VI) compounds are toxic to humans, animals and even aquatic organisms. They are used in many industries as electroplating, leather tanning, and stainless-steel production (Yarkandi, 2014) , but it is highly toxic causes multiorgan toxicity as hepatotoxicity, renal damage, and genotoxicity (Rana, 2008) . Inside cells, Cr (VI) is reduced to Cr(III) by a variety of chemical reductants with production of reactive intermediates causing cellular damage and generation of reactive oxygen species (ROS) (Myers, 2012) that enhances oxidative stress and exert a cytotoxic effect and many diseases as renal disorders, liver disorders, inflammation and others (Soudani et al., 2011) .
M
Vitamin E (lipid soluble antioxidant) could prevent membranes or proteins damage by scavenging ROS (Traber and Atkinson, 2007) , attenuate the oxidative stress and restore the level of anti-oxidants including glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) (Bharrhan et al., 2010) .
Selenium is an one of the essential micronutrients with antioxidant activity (MacFarquhar et al., 2010) counteracts the free radicals , preserve the structure and function of DNA, proteins and chromosomes against the injury of oxidation (ElDemerdash, 2004) .
So the aim of the present study was to evaluate the hepatotoxicity, nephrotoxicity and genotoxicity induced by acute Cr(VI) toxicity. Also, to evaluate and compare the possible protective role of vitamin E (vit. E) and selenium (Se) against that toxicity.
1. Hexavalent Chromium [Cr(VI)] in its synthetic-form potassium dichromate (K2Cr2O7). 2. Selenium in the form of selenium dioxide . 3. Vitamin E (α-tocopherol) in the form of oil.  Both Cr(VI) and selenium were purchased from Arab Company for Drug Industries and Medical Appliances, Abidin, Cairo, Egypt.  Vitamin E (α-tocopherol) was purchased from Cairo Company for Pharmaceutical and Chemical Industries, Shubra Cairo, Egypt.  potassium dichromate (K2Cr2O7) solution was prepared by dissolving 140 mg of K2Cr2O7 in 70 ml of distilled water to give the estimated dose for each rat.  Selenium solution was prepared by dissolving 7 mg of Selenium in 28 ml of distilled water to give the estimated dose for each rat. Collection and preservation of the samples Twenty four hours after the last dose; blood samples were taken from the medial canthus of the eyes of rats .The samples were collected in clean dry test tubes and left at room temperature for 20 minutes to clot. Samples were centrifuged at 4,000 rpm for 15 minutes to separate the sera.
The sera were then stored at -20 °C for subsequent assaying of Liver function tests (AST, ALT, ALP, total bilirubin), total protein, kidney function tests (urea, creatinine), oxidative stress markers (MDA), antioxidant markers (GSH, CAT, SOD).
Then all animals were sacrificed while they were under anesthesia by diethyl ether inhalation. Liver and both femurs were dissected. Parts of the livers were washed with phosphatebuffered saline (PBS) to remove any red blood cells or clots, then stored at -20°C for subsequent assaying of oxidative stress marker [the liver malondialdehyde (MDA)] by using commercial kits.
Also, some parts of the livers are kept in normal saline and freezed for measuring deoxyribonucleic acid (DNA) damage by the comet assay. The bone of the femora were kept in the normal saline then stored at 20°C, the bone marrows were used for estimation of chromosomal aberrations.
All the previous parameters were done at cell Biology Department of National Research Center in Dokki (Cairo) and were done by using commercial Kits, which were purchased from Bio diagnostic company, Dokki, Giza, Egypt.
Statistical Analysis
All the data were tabulated and expressed as the mean ± standard deviation (S.D.) values. Comparing the values for different treated groups with the values for controls were done using one-way ANOVA test. Independent sample t-test were used to compare between the means of two studied groups. Probability (P-value), P-value ≤0.05 was considered significant, Pvalue ≤0.001 was considered as highly significant and P-value >0.05 was considered insignificant. Data were analyzed using Statistical Program for Social Science (SPSS).
The results

1) Biochemical studies a) Liver function tests:
Cr (VI) resulted in elevation of the serum level of AST, ALT, ALP and total bilirubin as compared with the control. Administration of selenium (Se)or vitamin E (vit. E) with Cr(VI) resulted in lowering of serum level of AST, ALT, ALP and total bilirubin as compared to Cr(VI) toxic groups ,treatment with vit. E. showed more reduction in the serum level of AST, ALT and total bilirubin than treatment by Se ( Table 1) . b) Total protein in the serum:
Cr (VI)produced reduction in the serum level of total protein as compared to the control. Administration of Se or vit. E with Cr(VI), resulted in elevation of the serum level of total protein as compared to Cr(VI) toxic group with no significant differences between them (Table 2) . c) Kidney function tests:
Cr(VI) resulted in elevation of the serum level of urea and creatinine as compared to the control group. Co-administration of Se or vit. E with Cr(VI) showed significant decrease of urea concentration and creatinine level in the serum as compared to Cr(VI) toxic group with better effects observed with vit. E. (Table 3 ).
d) Oxidative stress markers:
Cr(VI) resulted in elevation of the level of liver malondialdehyde (MDA) as compared to the control group. Treatment by Se or vit. E with Cr(VI) induced reduction in the level of liver MDA as compared to Cr(VI) toxic group with no significant difference between them (Table 4 ). e) Antioxidant markers:
Administration of Cr(VI) produced increase in superoxide dismutase (SOD) activity and decrease in the serum level of GSH and catalase activity as compared to the control. Treatment by Se or vit. E with Cr(VI) revealed reduction in SOD activity and increase in the serum level of reduced GSH and catalase activity as compared to Cr(VI) toxic group, treatment by vit. E produced more improvement in SOD activity and catalase activity than the treatment by Se, with no significant difference between them as regards GSH (Table 5 ).
Genotoxic analysis (cytogenetic evaluation) a) Comet assay (The single cell Gel Electrophoresis [SCGE]):
Cr(VI)revealed elevation of DNA damage as indicated by increase in comet tail length (photo 2) as compared to the control(photo 1). Treatment by Se or vit. E resulted in decrease in DNA damage as compared to Cr(VI) toxic group, with no significant differences between them (Table 6 ).
(b) Chromosomal aberrations study:
Cr(VI) toxicity resulted in increase in all forms of chromosomal aberrations including Gap, Break, centromeric attenuation (C.A.), end mitosis(E. mitosis), deletion (Del.), fragments (Frag.) and end to end chromosome fusion (E to E) ( photo 5-10). Treatment Se or vit. E resulted in decrease in all forms of chromosomal aberrations, with no significant difference between them (Table 7&8) . Table ( 
Discussion
Acute C r(VI) toxicity resulted in significant increase in the levels of serum AST, ALT, ALP and total bilirubin as compared to the control group. These findings agreed with those of Hashish and Elgaml (2016) and can be explained by Giannini et al., (2005) who reported that the hepatotoxicity of chromium resulted in increase of the hepatic enzymes activity (AST and ALT) as they are located in the liver cell cytoplasm and after cellular damage, they are released in the blood stream. Also, (Soudani et al., 2013) stated that the chromium leads to disturbance in biosynthesis of hepatic enzymes due dysfunction and alteration in the permeability of the hepatic membrane.
In the present study, co-administration of selenium (Se) or vitamin E (vit. E) with Cr(VI) to rats resulted in significant decrease in serum levels of AST, ALT, ALP and total bilirubin as compared to acute Cr(VI) toxic group. These results were in agreement with those of (Balakrishnan et al., 2013a) .
The results of the present work revealed significant decrease in the total protein level in the serum in acute Cr(VI) toxic group as compared to the control group .These results were in agreement with those of (Hashish and Elgaml, 2016) . Yousef et al., (2008) revealed that to the reduction in protein synthesis or increase proteolytic activity or degradation that caused by Cr(VI) toxicity . In addition, Shati (2014) stated that the protein and glycogen content are decreased in response to K2Cr2O7 administration may be due to the harmful effect of its active metabolite.
In this study, co-administration of Se or vit. E with Cr(VI) showed significant increase in the total protein level in the serum as compared to acute Cr(VI) toxic group.This finding almost agreed with those of Balakrishnan et al., (2013a and b) .
The results of present study revealed significant increase in urea concentration and creatinine level in the serum as compared to the control group and this was in accordance with those of Salamaa et al., (2016) and supported by Patlolla et al., (2009) who said that the peroxidative damage by Cr(VI) causes reduction in kidney function, which was reflected by significant increase in serum levels of blood urea nitrogen (BUN) and creatinine suggesting nephrotoxicity.
In present study, co-administration of Se or vit. E with Cr(VI) to rats, produced significant decrease in urea concentration and creatinine level in the serum as compared to acute Cr(VI) toxic group. These results were in agreement with Balakrishnan et al., (2013a and b) .
Acute Cr(VI) toxic group revealed a significant increase in the level of liver malondialdehyde (MDA) as compared to the control group .Similar finding was reported by Goodarzi et al., (2016) and Hegazy et al., (2016) while Cengiz et al., (2016) observed that the level of MDA had not changed in K2Cr2O7 treated rats as compared to the control group.
The increase in the level of MDA due to Cr(VI) toxicity can be explained by Patlolla et al., (2009) who reported that Cr(VI) can induce free radical production leading to peroxidation with increase the peroxidation markers as MDA and decrease the antioxidant markers as SOD and reduced glutathione.
Similar to Mehany et al., (2013) coadministration of Se or vit. E with Cr(VI) in this study produced significant decrease of liver MDA level as compared to acute Cr(VI) toxic group.
In the present study, there were significant increase in superoxide dismutase (SOD) activity and significant decrease in the serum level of reduced glutathione (GSH) and catalase activity in acute Cr(VI) toxic group as compared to the control group similar to Goodarzi et al., (2016) .However, Cengiz et al., (2016) observed that SOD, catalase and reduced GSH levels had not changed in K2Cr2O7 treated rats .
The findings of the current work were explained by Amin et al., (2011) who reported that the increase in antioxidant enzymes activities suggests a response toward increased reactive oxygen species (ROS) generation. The mechanism by which Cr(VI) increased the ROS was explained by Zhang et al., (2011) who stated that the Cr(VI) generates free radicals, which in turn activate O2 and produce ROS as hydroxyl radicals and hydrogen peroxide and so lead to DNA damage.
In the present study, co-administration of Se or vit. E with Cr(VI) produced significant decrease in SOD activity and significant increase in the serum level of reduced GSH and catalase activity as compared to acute Cr(VI) toxic group. This was in agreement with Mehany et al., (2013 ) and could be explained by Flora et al., (2002) who stated that selenium play important metabolic role in mammalian cell due to its function in the active site of many antioxidant enzymes as glutathione peroxidase and glutathione reductase.
In the current study, there was significant increase in DNA damage as indicated by increase in comet tail length in acute Cr(VI) toxic group as compared to the control group which improved by treatment of rats with Se or vit. E. Patlolla et al., (2009) stated that comet tail length is an important parameter in evaluating the DNA damage (comet assay). This finding almost agreed with those of Cengiz et al., (2016) and explained by Stohs et al., (2001) who reported that Cr(VI) is involved in generating reactive oxygen species (ROS) leading to generation of oxidative stress, which is responsible for many toxic effects in the cell including lipid peroxidation, DNA damage and protein modification. Also, O'Brien et al., (2003) stated that the mechanism by which Cr (VI) induce genotoxicity may be due to the intracellular reduction of Cr(VI) into Cr(III) with production of chromium metabolite radicals that lead to different forms of DNA damage as breaking of the strand.
In agreement with Raju et al., (2012) the present study revealed significant increase in all forms of chromosomal aberrations in the bone marrow cells of adult male albino rats in acute Cr(VI) toxic group as compared to the control group that improved by treatment with Se or vit. E.
Conclusion
Concerning the results of the present study; it could be concluded that chromium compounds are very toxic and administration of selenium or vit E could play role against them.
Recommendation
So it is recommended to do regular medical examination of workers exposed to hexavalent chromium for early detection of any health problem and afford dietary supplementation with vitamin E and selenium.
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